Genzyme Corporation recalls Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva Pharmachemie Swensweg
Recalled November 22, 2017 · FDA recall D-0075-2018 · Genzyme
Hazard
Labeling: Incorrect or Missing Package Insert. · FDA Class III
Units
9,343 single dose vials
Sold at
Nationwide
Description
Labeling: Incorrect or Missing Package Insert.
Product
Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva Pharmachemie Swensweg 5 Haarlem, The Netherlands Mfd. for: Genzyme Corporation, Cambridge, MA 02142, NDC 0024-5860-01.
Manufacturer(s)
Genzyme Corporation
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →